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What this paper adds 
An angiosome is a block of tissue supplied by a specific artery comprising of skin, subcutaneous 
tissue, fascia, muscle and bone.  The foot and ankle comprise six angiosomes, supplied via the tibial 
vessels.  Revascularisation of tibial vessels (via surgical or endovascular means) for localised tissue 
loss can be performed directly to the affected angiosome (direct revascularisation (DR)), or not 
(indirect revascularisation (IR)).  This systematic review and meta-analysis shows that DR results in 
improved wound healing and limb salvage rates compared to IR, with no difference in overall 
mortality or re-intervention rates. 
Objectives 
The aim of this systematic review was to evaluate outcomes of direct revascularisation (DR)  vs. 
indirect revascularisation (IR) of infrapopliteal arteries to the affected angiosome for critical limb 
ischemia. Both open and endovascular techniques were included. 
Methods 
A systematic review of key electronic journal databases was undertaken from inception to 
September 2013. Studies comparing DR vs. IR in patients with localised tissue loss were included. 
Meta-analysis was performed for wound healing, limb salvage, mortality and re-intervention rates, 
with numerous sensitivity analyses. Quality of evidence was assessed using the GRADE system. 
Results 
13 cohort studies reporting on 1725 individual limbs were included (endovascular revascularisation: 
1199 limbs, surgical revascularisation: 450 limbs, both methods: 76 limbs). GRADE quality of 
evidence was low or very low for all outcomes. DR resulted in improved wound healing rates 
compared to IR (OR: 0.41, 95 per cent confidence interval (CI) 0.30-0.57, p<0.00001), and improved 
limb salvage rates (OR: 0.23, 95 per cent CI 0.11-0.48, p<0.00001), although this latter effect was lost 
on high quality study sensitivity analysis. Wound healing and limb salvage was improved for both 
open and endovascular intervention. There was no effect on mortality (OR: 0.72, 95 per cent CI 0.45-
1.15, p=0.17) or re-intervention rates (OR: 0.44, 95 per cent CI 0.10-1.88, p=0.27). 
Conclusion: 
DR of the tibial vessels results in improved wound healing and limb salvage rates compared to IR, 
with no effect on mortality or re-intervention rates. 
 Introduction 
Taylor and Palmer first described the anatomical concept of the angiosome as a block of tissue 
comprising of the skin, subcutaneous tissue, fascia, muscle and bone, supplied by a specific artery 
and drained by a specific vein1,.  Of the 40 angiosomes throughout the body, the foot comprises of 
six, arising from the posterior tibial artery (three), peroneal artery (two) and anterior tibial artery 
(one) (figure 1)2, 3.  Critical limb ischemia with disease affecting the infrapopliteal vessels presents a 
well-recognised challenge to the vascular surgeon and interventionist4. 
When planning endovascular or open surgical intervention, target vessel selection is typically 
dependant on the quality of the outflow vessel and its run-off5, 6. Recent evidence has suggested that 
direct revascularisation (DR) of the ischaemic area (i.e. to the angiosome containing the area of 
tissue loss) resulted in superior outcomes compared to indirect revascularisation IR during 
endovascular intervention3, 6-8. This is the same principle as restoring inline flow during open 
infrainguinal bypass surgery5.  However, indirect revascularisation (IR) may be perfectly adequate 
when sufficient collaterals are present, as angiosomal reperfusion will occur via these collaterals.6-8 
In addition, endovascular IR may be less risky than DR as there is a perception that target vessel loss 
after DR may result in a complete loss of blood supply to the affected region. 
The evidence concerning the use IR and DR is considered equivocal. While open surgical 
revascularisation is fairly consistent, endovascular practice varies widely. The aim of this systematic 
review was therefore to evaluate the outcomes of both endovascular and open DR vs. IR of the 
infrapopliteal vessels. 
 
 Methods 
 Data sources, search strategy and selection criteria 
A systematic review was undertaken utilising the Cochrane collaboration specified protocol9, and 
reported as per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
statement for the conduct of meta-analyses of interventional studies10. The following sources were 
searched without date restrictions: PubMed, Medline via OVID, Embase, the Cochrane Library 
Database and the Current Controlled Trials register.   Studies reporting comparisons of DR vs. IR in 
patients with critical limb ischemia were included. There was no limitation on publication type or 
language.  In the absence of an appropriately specific MeSH term, the free text search term 
'angioso*' was used, which captured the following search terms: angiosoma, angiosomal, 
angiosome, angiosomes, angiosomic, angiosonics, angiosonographic, angiosonography, 
angiosonoplasty and angiosorus.  An extensive search was also conducted using the 'related articles' 
function in PubMed, of which the results were limited to human research in the English language, 
with review articles excluded.  In addition the European Journal of Vascular and Endovascular 
Surgery, Journal of Vascular Surgery and British Journal of Surgery websites were searched 
individually.  The last search date was 28th September 2013. Outcome events were captured when 
two or more papers presented extractable data. 
Studies reporting outcomes comparing DR with IR of the infrapopliteal vessels in patients with 
critical limb ischemia of non-traumatic aetiology were included. Non-English language papers were 
excluded, as were papers arising, or suspected of arising, from duplicate publications.   
 Data extraction, outcome measures and assessment of study quality  
Data extraction and assessment of methodological quality was performed independently by two 
authors (DCB and CPT).  On cases of disagreement a consensus was reached amongst all authors.  
Extracted data consisted of: first author, year of study, study type and design (including if 
retrospective or prospective, single or multiple centres, if consecutive patients were enrolled), 
number of participants and individual limbs undergoing revascularisation, duration of follow up, 
modality of revascularisation (endovascular or surgical bypass), target vessel of revascularisation and 
quality of study. Angiosomes were considered grouped for tibial ('parent') vessel revascularisation 
(i.e. n=three), and individually for pedal revascularisation (n=six).  A number of papers presented 
propensity matched data due to significant baseline differences between patient groups. Propensity 
matched data was extracted preferentially.  Data were extracted at one year follow up where 
available, or if not given, at maximal follow up.   
Outcome measures were defined as: 
1. Wound healing rate - defined as complete epithelialisation of the target lesion with or 
without adjunct intervention (e.g. debridement, grafting etc). 
2. Limb salvage - defined as absence of major amputation (i.e. proximal to the tarsometatarsal 
joint). 
3. Mortality 
4. Re-intervention rate 
Outcomes were collected and analysed for individual limbs, except for mortality which was analysed 
for individual patients, when data were available. 
Study quality was assessed using the Newcastle-Ottawa (NO) score, which assigns points depending 
on the quality of patient selection (maximum four points), comparability of the cohort (maximum 
two points) and outcome assessment (maximum three points)11.  Studies ǁith a scoƌe ≥ siǆ ǁeƌe 
considered to be of higher quality. 
 Statistical analysis and evidence rating 
Meta-analysis was undertaken in Review Manager version 5.2.6 (RevMan; Nordic Cochrane Centre, 
Copenhagen, Denmark).  Dichotomous data were analysed using odds ratio (OR) as the summary 
statistic, and reported with 95 per cent confidence intervals (CI).  When required, data were 
extracted from Kaplan Meier curves by the methods described by Parmar12.  Random-effects model 
using the Mantel-Haenszel method were used (assuming significant heterogeneity between studies).  
Heterogeneity was assessed using an I2 calculation.   
Sensitivity analysis was performed when more than two studies were available for inclusion, and for 
the following subgroups: endovascular treatment alone, surgical bypass alone, larger studies 
;Ŷ<ϭϬϬͿ, those ǁith pƌopeŶsitǇ ŵatched gƌoups, those ǁith a Neǁcastle Ottaǁa scoƌe of ≥ siǆ aŶd 
those with follow up given at one year. 
Rating of the quality of evidence and strength of recommendation was undertaken using the 
Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, as per 
Cochrane collaboration recommendation13.  Quality was assessed depending on: risk of bias, 
indirectness of evidence, heterogeneity, imprecision of results and publication bias. Cohort studies, 
by definition, have a 'low' quality of evidence prior to further quality assessment.  The presence of 
one or more serious limitations results in a 'very low' grade of evidence.  A serious effect on quality 
of evidence was considered to occur when >50 per cent of included papers evidenced a risk of bias.  
Inconsistency was defined as an I2 of >50 per cent.  Indirectness was assumed not to occur in this 
setting.  Imprecision was defined as <50 patients in either cohort. A serious effect on quality of 
evidence was considered to occur when >50 per cent of included papers evidenced a risk of 
imprecision.   Publication bias was assessed using funnel plots for outcomes with more than ten  
studies42. 
 
 Results 
 Paper search and selection process  
The initial search yielded a total of 1319 results, of which 28 papers were retrieved for full 
evaluation.  Seven conference proceedings were included within this full evaluation.  A total of 13 
papers (of which two were conference proceedings) fulfilled the inclusion criteria and were included 
in the subsequent review (figure 2)14-26.  Excluded papers of note include three duplicate 
publications27-29 and one paper where data was non-extractable30.  All included papers were cohort 
studies comparing outcomes of direct revascularisation (DR) to the angiosome (or angiosomes) vs. 
indirect revascularisation (IR).  A total of 1725 limbs were available for evaluation. 
 Study design and baseline characteristics 
Study characteristics are given in table 1.  Revascularisation was entirely endovascular in seven 
papers (1199 limbs)14, 16, 17, 20, 21, 23, 24, via bypass surgery in five papers (450 limbs)15, 18, 19, 22, 26, and by 
both methods in one paper (76 limbs)25.  Detailed breakdown of outcomes for endovascular and 
bypass revascularisation were not available for the latter paper, which was therefore excluded from 
relevant sensitivity analyses. Revascularisation policy was specifically mentioned in four papers; 
preferentially to the angiosome of the target tissue loss in two14, 16, whilst the other two papers gave 
no regard to the affected angiosome15, 26.  Details of the target vessel revascularised were given in 
five papers17, 19, 23, 25, 26, although one provided these data prior to propensity matching23 (see table 
2).  Patients undergoing DR were more likely to undergo revascularisation to the anterior 
tibial/dorsalis pedis artery, and less likely to undergo revascularisation to the peroneal artery, 
compared to the IR group (p<0.0001).  Propensity matched groups were provided in three papers15, 
17, 23, with equivalent baseline characteristics between groups.  For the remaining papers, baseline 
differences (i.e. patient co-morbidities, disease location/extent, and revascularisation mode) were 
significantly different in the DR and IR groups in one paper18, whilst no significant differences were 
noted in four19, 21, 25, 26.  Three papers included diabetic patients exclusively14, 16, 23.  There were six 
high ƋualitǇ papeƌs ;NO scoƌe ≥ siǆͿ15-17, 22, 23, 26.  GRADE quality assessment was 'low' or 'very low' for 
all outcomes (table 3), suggesting caution is taken when drawing conclusions from the following 
data. 
 Outcomes 
Data regarding wound healing were given in ten papers (1038 limbs)14-16, 18-20, 22, 23, 25, 26.  
Heterogeneity amongst these studies was low (I2=0 per cent).  Meta-analysis showed that DR was 
associated with a significantly greater wound healing rate compared to IR (OR: 0.41, 95 per cent CI 
0.30-0.57, p<0.00001).  This effect was maintained in all sensitivity analysis (figure 3, table 4), with a 
relatively consistent OR (subgroup test for differences: I2=0 per cent), and low heterogeneity 
throughout.    
Limb salvage rates were presented in 12 papers (1632 limbs)15-26.  Heterogeneity amongst these 
studies was high (I2=77 per cent).  Meta-analysis showed that DR was associated with a significantly 
improved limb salvage rate compared to IR (OR: 0.23, 95 per cent CI 0.11-0.48, p<0.0001).  This 
effect was maintained on sensitivity analysis for endovascular and bypass revascularisation, and for 
larger studies.  However, this significance was lost for studies with propensity matched groups, a NO 
scoƌe of ≥ siǆ, aŶd those giǀiŶg folloǁ up at oŶe Ǉeaƌ, although oŶlǇ ŵaƌgiŶallǇ in the latter two 
groups (table 4, subgroup test for differences: I2=39.7 per cent).  Heterogeneity varied within the 
sensitivity analysis from 0 to 88 per cent.   
Mortality rates were presented in six papers (719 limbs)17, 18, 21, 23, 25, 26.  Heterogeneity amongst these 
studies was relatively low (I2=25 per cent).  Meta-analysis showed that the method of 
revascularisation had no effect on mortality rates (OR: 0.72, 95 per cent CI 0.45-1.15, p=0.17, figure 
4).  Similar results were obtained on a variety of sensitivity analysis (table 4, not analysed for bypass 
revascularisation due to lack of studies).  Heterogeneity varied within the sensitivity analysis from 0 
to 53 per cent.   
Rates of re-intervention were given in two papers (369 limbs)16, 23.  Heterogeneity amongst these 
studies was high (I2=70 per cent).  Meta-analysis showed that the method of revascularisation had 
no effect on re-intervention rates (OR: 0.44, 95 per cent CI 0.10-1.88, p=0.27).   
 
 Discussion  
This systematic review identified 13 cohort studies reporting on 1725 limbs, comparing the effect of 
direct and indirect angiosomal revascularisation. Meta-analysis showed that DR resulted in improved 
wound healing rates compared to IR for both open and endovascular intervention.  Limb salvage 
rates were also improved in the DR group compared to the IR group, although this significance was 
lost on sensitivity analysis of higher quality studies.  DR had no effect on long term mortality or re-
intervention rates.   
 Strengths and weaknesses 
This study represents the only systematic review and meta-analysis of DR vs. IR for CLI to date.  An 
extensive search for relevant studies was undertaken, the majority of included papers were recent 
publications, and numerous sensitivity analyses were performed.   There are limitations to this meta-
analysis, as all papers reviewed were observational studies and most were retrospective.  Less than 
half of the studies were high quality according to their NO scores15-17, 22, 23, 26.  Only four papers 
clearly defined their practice regarding revascularisation14-16, 26, of which two would preferentially 
attempt DR over IR leading to selection bias14, 16.  Propensity matched groups, and therefore higher 
quality data, were only provided in three studies15, 17, 23.   Outcomes for wound healing rates were 
maintained across sensitity analyses, but not for limb salvage.  Heterogeneity was high on certain 
sensitivity analyses.  For these reasons, GRADE assessment of quality of evidence was either low or 
very low.   
A further weakness is that no studies were adequately powered randomised trials comparing DR and 
IR.  The only comparative study to date compared a non-angiosomal (from 2001-05) and angiosomal 
(from 2005-10) revascularisation policy in a single unit27.   Preferentially revascularising according to 
the  angiosome model (i.e. attempting DR where feasible) resulted in a significant improvement in 
wound healing and limb salvage, but not in long term survival, consistent with the results of this 
meta-analysis.  
 Explaination of findings and implications for practice 
The improved outcomes seen with DR compared with IR may be explained by the absence of 
adequate inter-angiosomal collaterals, typically seen in patients requiring tibial revascularisation 6, 31, 
32. In the only study to date to examine this, Valera et al. compared outcomes of DR to IR in patients 
with and without adequate collatateral vessels as demonstrated on angiography25.  DR 
demonstrated superior outcomes to IR in those deemed as having absent collaterals.  However 
when adequate collaterals were present, IR was comparable to DR.  The absence of collateral vessles 
may prove vital in assessing which patients should be agressively targeted for DR. However, due to 
the pattern of disease, DR is occasionally technically impossible.  Kret et al. and Rashid et al. 
reported only 62% and 47% of patients had disease eligible for DR22, 26, whilst Alexandrescu et al. 
achieved DR in 80% of limbs27.  This difference may reflect selection bias or different patient 
populations. Extensive tissue loss or infection may preclude surgical access to gain DR even when 
arteries are suitable for bypass15.  Whilst it is clear DR is not always a suitable or viable option, this 
meta-analysis suggests that the angiosome concept should be considered when planning for distal 
revascularisation, and DR should be utilised preferentially to IR when it is avaliable as a safe option33.  
A significant number of studies employed tibial angioplasty. Whilst long term patency rates for 
endovascular intervention in the tibial vessels may be low34, any improvement in arterial supply 
(albeit temporary) may be sufficient for wound healing4, especially in patients with significant co-
morbidities or deemed unsuitable for surgical bypass4, 35, 36. However there remains some debate as 
to the long term value of tibial angioplasty, with conservative treatment from some centres showing 
similar long term outcomes37, 38.  Presuming intervention is useful, this meta-analysis suggests that 
endovascular DR improves wound healing and limb salvage rates. Importantly, there was no increase 
in adverse outcomes (mortality or re-intervention rates) with DR.  Some units now perform DR and 
IR during the same session. There were no comparable data on this technique, but multiple 
angioplasties result in improved outcomes compared to single lesion angioplasties39.  Theoretically, a 
combined DR and IR would overcome any problems with inadequate inter-angiosomal 
collateralisation17.  
On sensitivity analysis, DR was (non-significantly) less beneficial for bypass surgery compared to 
endovascular treatment for both wound healing and limb salvage rates. This may reflect the fact that 
open surgery is still preferentially chosen when the patient is fit or when good outflow vessels are 
present. Open IR is performed so selectively in the presence of excellent collateralisation, that 
outcomes would be expected to approach DR.  In contrast, IR may be attempted endovascularly with 
disease deemed unsuitable for bypass.  This could result in a greater rate of failed IR, making DR 
appear better when undertaken endovascularly compared to open.  
 Conclusion 
There is a benefit of DR for localised tissue loss to improve wound healing and limb salvage rates 
compared to IR, although this is low quality evidence.  Overall there was no difference in mortality or 
reintervention rates with DR compared to IR.  This meta-analysis suggestes that the angiosome 
concept should be considered when planning distal revascularistion and that direct revascularisation 
should be performed preferentially. While generally accepted for open surgery, this is the first 
collated evidence to support this during endovascular intervention. 
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FIgure legends  
 
Figure 1. Angiosomes of the foot and ankle.  Three main arteries supply the six angiosomes of the 
foot and ankle. Left: The dorsum of the foot and dorsum side of the toes are supplied by the anterior 
tibial artery (ATA) and dorsalis pedis artery. Middle: The posterior tibial artery (PTA) is the major 
supply to the plantar aspect of the foot via three angiosomes comprising of the calcaneal branch to 
the heel, the medial plantar artery to the medial foot, and the lateral plantar artery to the lateral 
foot. Right: The lateral border of the ankle and the outside of the heel is supplied by the peroneal 
artery (PA). Figure reproduced with permision17.  
Figure 2. PRISMA chart detailing the identification process for eligible studies. 
Figure 3. DR versus IR: forest plot for wound healing; all papers and sensitivity analyses. 
Figure 4. DR versus IR: forest plot for mortality rates. 
 
 
 
 Tables  
Table 1.  Demographic data and Newcastle Ottawa score of included studies.  * Conference proceedings (abstract).  ND = no data. For outcomes: 1. wound 
healing, 2. limb salvage rates, 3. overall survival, 4. re-do/further procedure, 5. amputation free survival. 
 
Author (year) 
Retrospective 
/ prospective 
Number 
of 
centres 
Consecutive 
patients 
Vascular 
intervention 
Propensity 
matched 
groups 
Follow 
up 
(months) 
Patients 
(n) 
Limbs 
(n) 
DR 
(n) 
IR 
(n) 
Outcomes NO 
score 
(max 9) 
Alexandrescu 
(2008) 
Retrospective Multiple ND Endovascular No 
17.8 ND 102 85 17 1 4 
Azuma 
(2012) 
Retrospective Single ND 
Bypass 
surgery 
Yes 
24 ND 96 48 48 1,2 9 
Fossaceca 
(2013) 
Retrospective Single ND Endovascular No 
17.5 201 201 167 34 1,2,4 7 
Iida (2012) Retrospective Multiple Yes Endovascular Yes 18 236 236 118 118 2, 4, 5 8 
Kabra (2013) Prospective Single ND 
Bypass 
surgery 
No 
6 64 64 39 25 1,2,3 4 
Kret (2013) Retrospective ND Yes 
Bypass 
surgery 
No 
ND 97 106 54 52 1,2,3 6 
Neville 
Retrospective Single Yes 
Bypass 
No ND ND 43 22 21 1 4 
(2009) surgery 
Osawa 
(2013) 
Retrospective Single ND Endovascular No 
ND 38 51 29 22 1,2 4 
Oshima* 
(2012) 
ND ND Yes Endovascular No 
12 55 60 31 29 2, 3 4 
Rashid 
(2013) 
Retrospective Single Yes 
Bypass 
surgery 
No 
12 ND 141 66 75 1,2 7 
Soderstrom 
(2013) 
Retrospective Single Yes Endovascular Yes 
12 ND 168 84 84 1 8 
Soon* (2012) Retrospective ND ND Endovascular No ND 350 381 197 184 2 4 
Valera 
(2010) 
Retrospective ND Yes Both No 
12 70 76 45 31 1,2,3 5 
 
Table 2.  Target for revascularisation (either to named artery or branch of) for DR and IR, as given in 
four papers.  A significantly greater number of limbs in the DR group had revascularisation to the 
AT/DP, and fewer to the peroneal artery, when compared to the IR group (P<0.0001, Chi-squared 
test).    * Totals greater than limb number given in table two due to multiple angioplasties. 
 
Paper Direct revascularisation  Indirect revascularisation 
Anterior 
tibial/dorsalis 
pedis 
Posterior 
tibial/plantar 
arteries 
Peroneal 
artery 
Anterior 
tibial/dorsalis 
pedis 
Posterior 
tibial/plantar 
arteries 
Peroneal 
artery 
Iida* 105 72 46 77 54 54 
Kret 27 26 1 15 6 31 
Neville 11 6 5 8 8 6 
Valera 37 6 2 10 1 20 
Total 180 (52%) 110 (32%) 54 (16%) 110 (38%) 69 (24%) 111 (38%) 
 
 Table 3.  GRADE analysis and assessment of quality of evidence.  Risk of bias was assessed for each 
included paper, and was assumed to be present when a non-consecutive, or non-propensity 
matched cohort was analysed, or follow up did not reach 12 months.  
 
Outcome Limbs 
(studies) 
Risk of 
bias 
Inconsistency Indirectness Imprecision Publication 
bias 
Overall 
quality of 
evidence 
Wound 
healing 
1038 
(10) 
Serious No No Serious NA Very low 
Limb 
salvage 
1632 
(12) 
Serious Serious No Serious Serious Very low 
Mortality 719 (6) No No No No NA Low 
Re-
intervention 
rate 
369 (2) Serious Serious No No NA Very low 
 Table 4. Outcomes for DR and IR, summary of findings.  HG – heterogeneity  
 
Sensitivity 
analysis 
No. of 
studies 
(total 
limbs) 
DR (n) IR 
(n) 
HG I2 
(per 
cent) 
HG p 
value 
Odds ratio (95 
per cent CI) 
Overall 
effect 
Z 
p value 
Wound healing 
All studies 10 (1038) 639 399 0 0.63 0.41 (0.30-
0.57) 
5.40 <0.00001 
Endovascular 
revascularisation  
4 (522) 365 157 0 0.49 0.35 (0.23-
0.54) 
4.68 <0.00001 
Bypass 
revascularisation 
6 (516) 274 242 0 0.61 0.49 (0.30-
0.80) 
2.88 0.004 
Larger studies 5 (718) 456 262 0 0.67 0.43 (0.30-
0.62) 
4.52 <0.00001 
Propensity 
matched groups 
2 (264) 132 132 0 0.87 0.38 (0.21-
0.70) 
3.09 0.002 
NO>5 5 (712) 419 293 0 0.92 0.46 (0.32-
0.68) 
3.97 <0.0001 
One year FU 5 (682) 410 272 0 0.91 0.42 (0.28-
0.63) 
4.23 <0.0001 
Limb salvage 
All studies 12 (1632) 909 723 77 <0.00001 0.23 (0.11-
0.48) 
3.97 <0.0001 
Endovascular 
revascularisation 
6 (1097) 626 471 88 <0.00001 0.18 (0.06-
0.56) 
2.95 0.003 
Bypass 
revascularisation 
5 (459) 238 221 0 0.50 0.42 (0.22-
0.80) 
2.65 0.008 
Larger studies 6 (1233) 686 547 87 <0.00001 0.31 (0.11-
0.87) 
2.23 0.03 
Propensity 
matched groups 
3 (500) 250 250 0 0.50 0.67 (0.40-
1.11) 
1.56 0.12 
NO>5 6 (948) 537 411 87 <0.00001 0.28 (0.07-
1.08) 
1.85 0.06 
One year FU 4 (605) 299 306 16 0.31 0.59 (0.33-
1.06) 
1.76 0.08 
Mortality 
Overall 6 (719) 380 339 25 0.25 0.72 (0.45-
1.15) 
1.37 0.17 
Endovascular 
revascularisation 
3 (464) 233 231 0 0.98 1.02 (0.65-
1.58) 
0.07 0.95 
Larger studies 3 (510) 256 254 53 0.12 0.78 (0.38-
1.61) 
0.66 0.51 
Propensity 
matched groups 
2 (404) 202 202 0 0.91 0.13 (0.64-
1.65) 
0.12 0.90 
NO>5 3 (510) 256 254 53 0.12 0.78 (0.38-
1.61) 
0.66 0.51 
One year FU 4 (558) 278 280 0 0.53 0.89 (0.59-
1.35) 
0.54 0.59 
Re-intervention 
All studies 2 (369) 251 118 70 0.07 0.44 (0.10-
1.88) 
1.10 0.27 
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